Journal profile · Medicine-Rheumatology
ACR Open Rheumatology
ISSN 2578-5745 · Wiley · United States · Monthly · Founded 2019
ACR Open Rheumatology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.9 (journal website); fully open access; APC about USD 3,910; median 101 days to acceptance (90 articles, last 24 months); acceptance rate 43% (journal website); 194 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
ACR Open Rheumatology is published by Wiley and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research and Spondyloarthritis Studies and Treatments, together about 39.3% of its articles. Its main subfields are Rheumatology. (generated from OpenAlex topic counts and CAS ranking data)
<em>ACR Open Rheumatology</em> is the official open access rheumatology journal of the American College of Rheumatology publishing quality articles, reviews & commentaries.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Rheumatology
Editor-in-chief Andras PerlPublisher website
Editorial board by country: 1 in mainland China (about 2%); most named United States 46, New Zealand 2, Hungary 2, Mainland China 1, United Kingdom 1 (54 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Rheumatoid Arthritis Research and TherapiesMedicine21.9%
- Systemic Lupus Erythematosus ResearchMedicine8.9%
- Spondyloarthritis Studies and TreatmentsMedicine8.6%
- Autoimmune and Inflammatory Disorders ResearchMedicine5.8%
- Systemic Sclerosis and Related DiseasesMedicine5.7%
- Vasculitis and related conditionsMedicine5.3%
- Inflammatory Myopathies and DermatomyositisMedicine4.7%
- Osteoarthritis Treatment and MechanismsMedicine4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Rheumatology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Rheumatology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 2.9Publisher website ·
- Impact factor (publisher) 2025
- 2.9Publisher website ·
- CiteScore 2026-06
- 4.1LetPub ·
- CiteScore (publisher)
- 4.1Publisher website ·
- CiteScore (publisher) 2025
- 4.1Publisher website ·
- SJR 2026-06
- 1.05LetPub ·
- SNIP 2026-06
- 0.95LetPub ·
- h-index
- 40OpenAlex ·
- i10-index
- 307OpenAlex ·
- 2-year mean citedness
- 2.06OpenAlex ·
- Self-citation rate
- 3.4%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 135LetPub ·
- Articles per year (publisher)
- 2Publisher website ·
- Articles per year (publisher) 2025
- 166Publisher website ·
- Downloads per year (publisher) 2025
- 372,817Publisher website ·
Articles by year OpenAlex count · 1,223 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 198 | 198 | 36 |
| 2025 | 194 | 194 | 516 |
| 2024 | 145 | 145 | 556 |
| 2023 | 136 | 136 | 832 |
| 2022 | 136 | 136 | 1,107 |
| 2021 | 183 | 183 | 2,349 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
101 daysMedian, submission to acceptance · P25–P75 51 days – 147 days
- Acceptance to online
- median 46 days (90 articles)
- Submission to online
- median 167 days
- Sample
- 90 articles with submission and acceptance dates (402 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 10 weeksLetPub ·
- Acceptance rate (publisher)
- 43%Publisher website ·
- Acceptance rate (publisher) 2025
- 43%Publisher website ·
- Submission to first decision
- 6 daysPublisher website ·
- Submission to first decision 2025
- 6 daysPublisher website ·
- Submission to acceptance 2025
- 87 daysPublisher website ·
- Acceptance to publication 2025
- 65 daysPublisher website ·
- Submission to publication (journal-reported)
- about 10 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,910 / GBP 2,940 / EUR 3,360 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 3,550 / EUR 3,050 / GBP 2,670 | — | — | |
| LetPub | USD 3,080 / GBP 2,310 / EUR 2,640 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Wiley
- Country or region
- United States
- Language
- English
- Frequency
- Monthly
- Founded
- 2019
- ISSN
- 2578-5745
- Society / sponsor
- American College of Rheumatology
- Latest issue on the website
- Volume 8, Issue 9 (September 2026)
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about ACR Open Rheumatology
What CAS zone is ACR Open Rheumatology in?
In the 2025 upgraded edition of the CAS Journal Ranking, ACR Open Rheumatology is in Zone 3 of Medicine, and in Zone 4 of the minor category Rheumatology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of ACR Open Rheumatology?
The journal's website gives an impact factor of 2.9 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 4.1, h-index 40.
How long does peer review take at ACR Open Rheumatology?
Based on the dates recorded on 90 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 101 days (interquartile range 51–147 days); authors report an average review time of about 10 weeks; the journal's website gives an acceptance rate of 43% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of ACR Open Rheumatology based?
Of the 54 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are United States (46), New Zealand (2) and Hungary (2). Counted from the institutions listed on the board page; for reference only.
Which databases index ACR Open Rheumatology?
According to LetPub and DOAJ records, ACR Open Rheumatology is indexed in ESCI, Scopus and DOAJ.
Is ACR Open Rheumatology open access, and what is the APC?
ACR Open Rheumatology is a fully open-access journal. APC about USD 3,910.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .